latest news releases from the newsroom
Colombia Goldfields Ltd.
Colombia Goldfields Signs $3 Million Exploration Deal
VANCOUVER, British Columbia, Sept. 29, 2005 (PRIMEZONE) -- Colombia Goldfields Ltd. (OTCBB:CGDF) is pleased to announce the signing of a definitive agreement with Investcol Limited, whereby the company has acquired an option to purchase a 100% interest in certain mining and mineral rights on three advanced gold properties known as the Caramanta concessions strategically positioned in the heart of the Marmato Mountain mining district.
Sciax Corp. Announces Name Change and Reverse Stock Split
BAY CITY, Mich. and TORONTO, Sept. 29, 2005 (PRIMEZONE) -- Sciax Corp. (Pink Sheets:SCXC) announced today that its Board of Directors have approved an amendment to Sciax's Certificate of Incorporation that would effect a name change to RMD Corp. and a reverse split of the shares of common stock at a ratio of 1 for 70. The company has filed with its transfer agent to request a new trading symbol and CUSIP number. Under the guidelines of regulatory and company act requirements the Directors deliberated the need and ratio of the reverse stock split and unanimously agreed that the restructuring is in the best interest of the Company. The company anticipates the effective date trading under the new symbol Oct. 14, 2005.
AutoZone Announces Organizational Change
MEMPHIS, Tenn., Sept. 29, 2005 (PRIMEZONE) -- AutoZone, Inc. (NYSE:AZO) today announced Michael Archbold, Executive Vice President and Chief Financial Officer, will resign effective tomorrow, September 30th. Mr. Archbold has accepted the position of Executive Vice President, Chief Financial Officer and Chief Administrative Officer with Saks Fifth Avenue Enterprises.
Detroit Poet Returns with 'So Many Selves'
DETROIT, Sept. 29, 2005 (PRIMEZONE) -- Marygrove College hosts the return of Detroit native and second-generation Arab American poet Lawrence Joseph on Thursday, Oct. 20 at 7:30 p.m., in Alumnae Hall, Madame Cadillac Building. Joseph will present his new volume of poems, "Into It," which includes a long poem "Woodward Avenue." Other poems in this volume are based on his harrowing experience on 9-11. Since that date, he has written of the tensions of being an Arab American in the post-9/11 U.S. from the perspective of one who lives blocks away from Ground Zero. He will also read from his newly issued collection "Codes, Precepts, Biases and Taboos: Poems 1973-1993," the collected poems from his first three books: "Shouting at No One" (1983), "Curriculum Vitae" (1988), and "Before Our Eyes" (1993). Besides poetry, Joseph has written a work of creative nonfiction, "Lawyerland: What Lawyers Talk About When They Talk about Law" (1997) as well as numerous essays and reviews.
Active Biotech Presents Survival Data on Cancer Drug
STOCKHOLM, Sweden, Sept. 29, 2005 (PRIMEZONE) -- Survival data for renal patients and the first generation (TTS CD2) of ANYARA will be presented at the NCRI (National Cancer Research Institute) conference held in Birmingham, UK, October 2-5.Forty-three renal cancer patients, included in a previously concluded multi-centre open label Phase II study (1) of Active Biotech's TTS CD2, were treated with individualized doses of TTS CD2. All patients were followed for survival and two year survival data have now been compiled.
Active Biotech: Confirmed ANYARA Tumor PET Localization in Cancer Patients
STOCKHOLM, Sweden, Sept. 29, 2005 (PRIMEZONE) -- In an ongoing clinical Phase I study, specific tumor localization of Active Biotech's candidate drug ANYARA, has now been objectively confirmed.Using Positron Emission Tomography (PET) and radioactively labeled ANYARA, drug concentrations in tumor and normal tissues of individual patients have been measured for the first time, demonstrating that ANYARA localizes to tumors that express the target antigen 5T4. The study is ongoing at Paterson Institute for Cancer Research and at Christie Hospital, Manchester, UK and the first results from this study will be presented at the NCRI (National Cancer Research Institute) conference held in Birmingham, UK on October 2-5.